Quest Diagnostics Forecasts FY2024 Adjusted EPS Of $8.72-$8.97 Versus Prior Guidance Of $8.60-$8.90 And Consensus Of $8.75
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics has updated its FY2024 adjusted EPS forecast to $8.72-$8.97, up from the previous guidance of $8.60-$8.90, surpassing the consensus estimate of $8.75.
April 23, 2024 | 10:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics raises its FY2024 adjusted EPS forecast, indicating stronger than expected financial performance.
Raising the EPS forecast suggests that Quest Diagnostics is performing better than previously anticipated, which is likely to positively influence investor sentiment and potentially lead to an increase in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100